Development of TMS for Treatment-Resistant Depression

Development of TMS for Treatment-Resistant Depression

Posted: November 15, 2008
Development of TMS for Treatment-Resistant Depression

Story highlights

 

With the help of a Young Investigator Grant, Scientific Council Member Mark S. George, M.D. developed Transcranial Magnetic Stimulation (TMS), a new kind of non-invasive brain stimulation as an alternative for electroconvulsive therapy (ECT) in treatment-resistant depression. In 1995, unable to get NIH funding for TMS, a NARSAD Young Investigator Grant allowed the work to gather important clinical information and served as "bridge" funding to set the stage for the emergence of this industry. Following the initial NARSAD Young Investigator Grant, numerous NIH, Department of Defense and VA awards valued at several millions of dollars furthered development of TMS until it received FDA approval in 2008.

Read a letter written by Dr. George about the importance and impact of BBRF Grants.

View a Meet the Scientist Webinar featuring Dr. George titled New Advances with Non-Invasive Brain Stimulation - TMS

Learn more about TMS: